Senior MD at Evercore. Ranked first team in largecap biotechnology, pharmaceuticals/major, pharmaceuticals/specialty.
Say what you will about ER, but being simultaneously #1 in 3 (albeit related) sectors is nuts. I'm sure he has an army of associates and VP's slaving away, but he must be towards the very top of highest paid ER Analysts.
Would $10 mil be a stretch for someone like that? If he can't rake in $10M a year then idk..
| +72 | Q&A - Buyside Equity Research Analyst/PM | 27 | 5d | |
| +31 | How the heck do you learn all of this stuff? | 5 | 2d | |
| +28 | Getting Frustrated | 10 | 2w | |
| +27 | My experience on the sell side | 20 | 1w | |
| +22 | What’s my next move? | 6 | 2w | |
| +20 | CS Major looking to switch and break into high finance - is it over for me? | 6 | 3w | |
| +20 | Vanderbilt vs. Notre Dame M.S. in Finance Equity Research placement | 10 | 3w | |
| +18 | Biotech ER vs IB | 16 | 2w | |
| +14 | Heard they don’t model at Oppenheimer | 10 | 1w | |
| +13 | ER time line and ways to break in help | 17 | 2w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
I could probably find out but whatever it is, it's probably deserved. Dude works insanely hard and rather than kick questions to his analysts, he answers everything personally and promptly at almost any time of day. Pretty crazy, and a good legacy to his predecessor.
isn't every big name investor wrong with absolute certainty at times?
Highest salary I’ve heard is Mike Yee. $4 million a year. I’m not saying Umer can’t or doesn’t make more.
4m is what’s guaranteed which caused a lot of outrage in 2022 when majority were taking pay cuts Was much more than $4m in 2021 boom. Source: I work at Jef.
Why would they pay more than his guarantee? Banks are protecting their upside risk and he’s protecting his downside risk in case of a slow year…
Isn't this already IB MD level? Throw in the fact that banking is cyclical while research is stabler so you have less diminishing marginal utility in research. So doesn't that mean that IB and ER are pretty equal monetarily at the MD level?
Only biotech bro. You’re not gonna get that in restaurants or something random.
I see. Well then, restaurant bankers or other random bankers won't be pulling that much too, right?
I believe that a number one II sell side research guy is definitely way more prestigious than an average PM at some notable hedge fund.
Know a guy who used to work for Umer and the figure was much higher than the $4M (Mike Yee)
That’s wild… wonder what the average biotech analyst/MD is making.
Any insights from buy-siders on why Umer/Michael Yee are so well regarded? What makes their research useful/helpful and differentiated?
Sint voluptatem aut delectus repellat illum. Optio omnis sit quo facere deserunt magnam maiores. Quia laboriosam facere iure dolore quidem vitae.
Et saepe asperiores et voluptatem. Maiores cupiditate ullam quia. Et eligendi illum similique.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...